Literature DB >> 11098945

Effects of inspired gas content during respiratory arrest and cardiopulmonary resuscitation.

A H Idris1.   

Abstract

Mouth-to-mouth and bag-valve-mask ventilation have been an indispensable part of cardiopulmonary resuscitation (CPR). However, only recently have the effects of different tidal volumes on arterial oxygenation been reported for mouth-to-mouth and bag-valve-mask ventilation. Currently recommended tidal volumes (10-15 mL/kg) are associated with an increased risk of gastric inflation because they produce high peak inspiratory pressures. An animal model of ventilation with an unprotected airway showed that a smaller tidal volume (6 mL/kg) is as effective as a larger tidal volume (12 mL/kg) in maintaining Sao2 at >96%. However, a smaller tidal volume with exhaled gas ventilation produced a mean Sao2 of 48%, which is ineffective. Ventilation gas mixtures have been studied in models of cardiac arrest and CPR. One study showed that ventilation with air during 6 mins of CPR resulted in a return of spontaneous circulation in 10 of 12 animals compared with only 5 of 12 animals ventilated with exhaled gas (p<.04). Arterial and mixed-venous Po2 were significantly higher, and Pco2 was significantly lower in the air ventilation group. Investigations of the cardiovascular effects of mouth-to-mouth ventilation during CPR suggest that there are adverse effects during low blood flow states. However, mouth-to-mouth ventilation during respiratory arrest is lifesaving and should continue to be taught and emphasized in basic life support courses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11098945     DOI: 10.1097/00003246-200011001-00006

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  1 in total

1.  Maximum FIO2 in minimum time depending on the kind of resuscitation bag and oxygen flow.

Authors:  Salvador Quintana; Jesús Martínez Pérez; Manuel Alvarez; Joan Salvador Vila; Fernando Jara; Juan Manuel Nava
Journal:  Intensive Care Med       Date:  2003-10-10       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.